Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple Sclerosis-related Uveitis: Does MS Treatment Affect Uveitis Course?
Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin.
Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
An unusually dry story.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
The role of dendritic cells in autoimmunity.
Disseminated Encephalomyelitis-Like Central Nervous System Neoplasm in Childhood.
Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
A prospective study of "undiagnosed" isolated myelopathy: II. Value of magnetic resonance imaging, evoked potentials and CSF analysis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.
microRNAs: A connection between cholesterol metabolism and neurodegeneration.
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Increasing consistency of disease biomarker prediction across datasets.
Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
The choroid plexus is modulated by various peripheral stimuli: implications to diseases of the central nervous system.
Pages
« first
‹ previous
…
552
553
554
555
556
557
558
559
560
…
next ›
last »